Tag #Roundup

Showing 1 to 5 of 5 results

sueddeutsche.de

🌐 85% Global Worthiness

Aug 1, 19:16

Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions

Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.

Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions

Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the net impact of Bayer's strong pharmaceutical performance and increased legal provisions on its financial outlook and market valuation?

Bayer raised its full-year sales and earnings forecast due to strong performance in its pharmaceutical division. However, the company announced additional provisions of €1.7 billion for legal disputes in the US, mainly for Roundup, a glyphosate-based herbicide, with the lion's share due to a negative US court ruling. Bayer stock rose 1.5 percent.

zeit.de

🌐 85% Global Worthiness

Apr 5, 01:19

Bayer Appeals Glyphosate Ruling to US Supreme Court

Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...

Bayer Appeals Glyphosate Ruling to US Supreme Court

Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key legal arguments Bayer is presenting to the Supreme Court regarding glyphosate lawsuits, and what is the potential immediate impact on the company?

Bayer, a German chemical company, appealed to the US Supreme Court due to conflicting rulings in US states regarding glyphosate-related lawsuits. The appeal focuses on a 2023 Missouri case, seeking a ruling to curb the thousands of lawsuits against its subsidiary, Monsanto, alleging Roundup caused health issues. Bayer emphasizes Roundup's safety, scientifically proven and confirmed by global authorities.

taz.de

🌐 75% Global Worthiness

Mar 12, 22:13

Germany Suspends Monsanto's Roundup Future Pesticide"

Germany suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future on Tuesday following an objection by the German Environmental Aid (DUH) due to concerns about its safety and environmental impact; the BVL will review the objection and hear Monsanto's response.

Germany Suspends Monsanto's Roundup Future Pesticide"

Germany suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future on Tuesday following an objection by the German Environmental Aid (DUH) due to concerns about its safety and environmental impact; the BVL will review the objection and hear Monsanto's response.

Progress

44% Bias Score

ShareSaveArticle

Life on Land

12345678

Previous 1 of 8 Next

What are the immediate consequences of the BVL's suspension of Roundup Future, and what is its significance for glyphosate use in Germany?

Germany's Federal Office of Consumer Protection and Food Safety (BVL) suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future following an objection by the German Environmental Aid (DUH). The DUH argues that glyphosate's safety is insufficiently proven and harms biodiversity. The BVL will now review the DUH's objection, hearing Monsanto's response before making a final decision.",

theguardian.com

🌐 85% Global Worthiness

Jul 6, 16:12

Diquat: Roundup's Toxic Replacement Under EPA Scrutiny

New research shows diquat, a glyphosate replacement in Roundup, damages gut bacteria and multiple organs, despite being banned in many countries but allowed in the US due to weak regulations and industry influence.

Diquat: Roundup's Toxic Replacement Under EPA Scrutiny

New research shows diquat, a glyphosate replacement in Roundup, damages gut bacteria and multiple organs, despite being banned in many countries but allowed in the US due to weak regulations and industry influence.

Progress

60% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the EPA's regulatory approach to diquat compare to other countries, and what factors contribute to this discrepancy?

The study details diquat's damage to the gut lining, reducing key proteins, allowing toxins into the bloodstream and triggering inflammation. It also harms kidneys, lungs, and liver, potentially causing multiple organ dysfunction syndrome. This contrasts with the EPA's inaction despite evidence of diquat's toxicity.

sueddeutsche.de

🌐 85% Global Worthiness

Mar 23, 16:11

Bayer Faces $2.1 Billion Roundup Verdict in Georgia

A Georgia jury ordered Bayer to pay $2.1 billion in a Roundup cancer lawsuit, one of the largest awards in the ongoing litigation involving the weed killer, which Bayer insists is not carcinogenic, despite a 2015 IARC classification and over 60,000 pending cases.

Bayer Faces $2.1 Billion Roundup Verdict in Georgia

A Georgia jury ordered Bayer to pay $2.1 billion in a Roundup cancer lawsuit, one of the largest awards in the ongoing litigation involving the weed killer, which Bayer insists is not carcinogenic, despite a 2015 IARC classification and over 60,000 pending cases.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate financial implications for Bayer following the $2.1 billion jury verdict in the Georgia Roundup lawsuit?

In a significant setback, a Georgia jury ordered Bayer to pay $2.1 billion to a plaintiff who claimed Roundup caused his cancer. Bayer announced an appeal, noting this is among the largest sums awarded in Roundup litigation and that they have already paid roughly $10 billion in legal settlements. Over 60,000 cases remain pending.

Showing 1 to 5 of 5 results